Microbiology Diagnostics Is Alive and Well - Beckman Coulter Adds to its Core Testing Solutions

Microbiology Diagnostics Is Alive and Well - Beckman Coulter Adds to its Core Testing Solutions

The following analysis is derived from Kalorama Information’s upcoming report on the global infectious disease test market. The report’s prior edition, The Worldwide Market for Infectious Disease Diagnostic Tests , is also available.

This post discusses the potentially undervalued move by Beckman Coulter to enter the market for traditional microbiology diagnostics or ID/AST systems at a time when many mid-sized and major IVD companies have focused on molecular diagnostic methods. Similarly aus...


With Next-Generation Sequencing, MDx Catches Up to Antimicrobial Resistance

With Next-Generation Sequencing, MDx Catches Up to Antimicrobial Resistance

Market information and other trends regarding next-generation sequencing and healthcare-acquired infections are available through Kalorama Information reports Next Generation Sequencing (NGS) Markets 2015 and Healthcare Associated Infection (HAI) Control Markets.

A powerful tool for the development of now ubiquitous molecular infectious disease assays, sequencing is also capable of directly impacting clinical decision-making and disease control as an in vitro diagnostic (IVD). Next generation ...


Top Five IVD Segments in the United States - Leaders in Forecast Growth

Top Five IVD Segments in the United States - Leaders in Forecast Growth

( This post represents the fifth and final installment of a weekly preview for Kalorama Information’s upcoming publication The US Market for In Vitro Diagnostic Tests. The posts review the projected top-performing IVD segments in the U.S. market through 2018. )

The United States is the most mature and diversified IVD market in the world, with many clinical tests first developed and approved in the country and most core testing segments already at market saturation. Established market segments ...